The study findings suggest that [99mTc]Tc-PSMA SPECT/CT has good diagnostic performance for prostate cancer, making it a valuable tool in regions and clinical settings where access to [68Ga]Ga-PSMA PET/CT may be limited. The gene discussed is FOLH1; the disease is prostate carcinoma.